Pudendal neuralgia is a painful, neuropathic condition involving the dermatome of the pudendal nerve. This condition is not widely known and often unrecognized by many practitioners. The International Pudendal Neuropathy Association (tipna.org) estimates the incidence of this condition to be 1/100,000; however, most practitioners treating patients with this condition feel the actual rate of incidence may be significantly higher. Currently, there is fair paucity of medical literature and scientific evidence in the diagnosis and treatment of pudendal neuralgia. Diagnosis of this condition is based on the utilization of Nantes Criteria, in conjunction with clinical history and physical findings. CT-scan guided nerve blocks are also employed, by this author, to provide additional information. Subsequent treatment of pudendal neuralgia is medical and well as surgical, with Physical Therapy a key component to all aspects of treatment. The goal of this paper is to present evidence based information, as well as personal clinical experience, in treating approximately 200 patients with pudendal neuralgia.
Purpose of review The purpose of this publication is to review the currently available and most up-to-date information regarding the pathogenesis, diagnosis, and treatment of pelvic congestion syndrome. Recent findings The diagnosis of pelvic congestion syndrome is difficult to make; however, it should remain on the differential for chronic pelvic pain. The most recent available research seems to favour endovascular treatment with interventional radiology over surgical management, with high success rate and low occurrence of complications. Summary High-level evidence on the diagnosis and management of pelvic congestion syndrome is lacking. Only a small number of randomized controlled trials exist. More high-quality research is needed, particularly involving practicing obstetrician and gynecologists as the majority of these patients, and the clinical outcomes of any interventions implemented for pelvic congestion syndrome are ultimately managed by OB/GYN providers.
Objective: To determine the prevalence of occult microscopic endometriosis in patients with chronic pelvic pain and negative laparoscopy. Methods: A retrospective cross-sectional study included women who underwent laparoscopic evaluation for chronic pelvic pain by three fellowship-trained gynecologic surgeons at a community hospital from January 2011 to December 2016. The aim was to evaluate the prevalence of microscopic endometriosis in this population. Results: In 142 patients with clinically negative peritoneum on laparoscopy, 39% had occult microscopic endometriosis. Cramping pain score during menses was found to be lower in the positive biopsy group (6.9 vs 8.0, P=0.046). No differences were appreciated in age of menarche, pain during various parts of the menstrual cycle, or duration of symptoms. The biopsy-positive group had a younger age at time of evaluation, although not statistically significant (P=0.179). Current use of hormones affected neither biopsy results nor menstrual or pain characteristics. Detection was similar between robotic and laparoscopic cases and operative morbidity was minimal. Conclusion: Occult microscopic endometriosis may be present in approximately 39% of patients with clinically negative appearing peritoneum undergoing laparoscopy for chronic pelvic pain. Given this, biopsies should be performed in patients undergoing laparoscopy who do not have visible lesions.
to study the "Effect of organic sources on growth, yield attributes and yield of summer clusterbean under organic farming". The experiment comprised of nine treatments viz. T1: 5.0 t/ha FYM, T2: 1.0 t/ha castor cake, T3: 2.5 t/ha FYM + 0.5 t/ha castor cake, T4: 5.0 t/ha FYM + NPK consortium, T5: 1.0 t/ha castor cake + NPK consortium, T6: 2.5 t/ha FYM + 0.5 t/ha castor cake + NPK consortium, T7: 5.0 t/ha FYM + Rhizobium + PSB, T8: 1.0 t/ha castor cake + Rhizobium + PSB, T9: 2.5 t/ha FYM + 0.5 t/ha castor cake + Rhizobium + PSB were evaluated in randomized block design replicating three times. Significantly higher plant height at 60 DAS and at harvest, Number of nodules per plant and dry weight of nodules per plant, number of pods per plant, seed yield per plant and seed index were recorded under treatment T9 Which was found at par with T6. In the case of Plant population at 30 DAS and at harvest, plant height at 30 DAS, Days to 50% flowering, Pod length, Number of seeds per pod treatments did not affected significantly. Significantly, higher seed yield (901 kg/ha) and stover yield (2709 kg/ha) were achieved with application of 2.5 t/ha FYM + 0.5 t/ha castor cake + Rhizobium + PSB (T9) which remained at par with treatment T6.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.